Selected research
Industry Growth & Trends
Global Nanotechnology-based Drug Delivery Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Nanotechnology-based Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Nanotechnology-based Drug Delivery market include AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, EyePoint Pharmaceuticals and Johnson and Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Nanotechnology-based Drug Delivery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nanotechnology-based Drug Delivery market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nanotechnology-based Drug Delivery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nanotechnology-based Drug Delivery.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Nanotechnology-based Drug Delivery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nanotechnology-based Drug Delivery Market by Company
AbbVie Inc.
BlueWillow Biologics Inc.
Camurus AB
Celgene, lnc.
Cristal Therapeutics
EyePoint Pharmaceuticals
Johnson and Johnson
Nanotechnology-based Drug Delivery Segment by Type
Nanocrystals
Nanoparticles
Liposomes
Micelles
Others
Nanotechnology-based Drug Delivery Segment by Application
Hospital
Research Institute
Others
Nanotechnology-based Drug Delivery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanotechnology-based Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanotechnology-based Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanotechnology-based Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nanotechnology-based Drug Delivery companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Nanocrystals
- Nanoparticles
- Liposomes
- Micelles
- Others
Applications
- Hospital
- Research Institute
- Others
Companies covered
- AbbVie Inc.
- BlueWillow Biologics Inc.
- Camurus AB
- Celgene, lnc.
- Cristal Therapeutics
- EyePoint Pharmaceuticals
- Johnson and Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Nanotechnology-based Drug Delivery Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Nanotechnology-based Drug Delivery Market Size by Region (2021-2032)
- 1.4.1 Global Nanotechnology-based Drug Delivery Market Size by Region (2021-2026)
- 1.4.2 Global Nanotechnology-based Drug Delivery Market Size by Region (2027-2032)
- 1.5 Key Regions Nanotechnology-based Drug Delivery Market Size (2021-2032)
- 1.5.1 North America Nanotechnology-based Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Nanotechnology-based Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.4 South America Nanotechnology-based Drug Delivery Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Nanotechnology-based Drug Delivery Market Size Growth Rate (2021-2032)
2 Nanotechnology-based Drug Delivery Market by Type
- 2.1 Type Introduction
- 2.1.1 Nanocrystals
- 2.1.2 Nanoparticles
- 2.1.3 Liposomes
- 2.1.4 Micelles
- 2.1.5 Others
- 2.2 Global Nanotechnology-based Drug Delivery Market Size by Type
- 2.2.1 Global Nanotechnology-based Drug Delivery Market Size Overview by Type (2021-2032)
- 2.2.2 Global Nanotechnology-based Drug Delivery Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Nanotechnology-based Drug Delivery Market Size Forecasted by Type (2027-2032)
- 2.3 Global Nanotechnology-based Drug Delivery Market Size by Regions
- 2.3.1 North America Nanotechnology-based Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Nanotechnology-based Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Nanotechnology-based Drug Delivery Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Nanotechnology-based Drug Delivery Market Size Breakdown by Type (2021-2026)
3 Nanotechnology-based Drug Delivery Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Research Institute
- 3.1.3 Others
- 3.2 Global Nanotechnology-based Drug Delivery Market Size by Application
- 3.2.1 Global Nanotechnology-based Drug Delivery Market Size Overview by Application (2021-2032)
- 3.2.2 Global Nanotechnology-based Drug Delivery Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Nanotechnology-based Drug Delivery Market Size Forecasted by Application (2027-2032)
- 3.3 Global Nanotechnology-based Drug Delivery Market Size by Regions
- 3.3.1 North America Nanotechnology-based Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Nanotechnology-based Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Nanotechnology-based Drug Delivery Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Nanotechnology-based Drug Delivery Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Nanotechnology-based Drug Delivery Industry Trends
- 4.2 Nanotechnology-based Drug Delivery Industry Drivers
- 4.3 Nanotechnology-based Drug Delivery Industry Opportunities and Challenges
- 4.4 Nanotechnology-based Drug Delivery Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Nanotechnology-based Drug Delivery Revenue (2021-2026)
- 5.2 Global Nanotechnology-based Drug Delivery Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Nanotechnology-based Drug Delivery Key Company Headquarters & Area Served
- 5.4 Global Nanotechnology-based Drug Delivery Company, Product Type & Application
- 5.5 Global Nanotechnology-based Drug Delivery Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Nanotechnology-based Drug Delivery Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Nanotechnology-based Drug Delivery Players Market Share by Revenue in 2025
- 5.6.3 2025 Nanotechnology-based Drug Delivery Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AbbVie Inc.
- 6.1.1 AbbVie Inc. Company Information
- 6.1.2 AbbVie Inc. Business Overview
- 6.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Product Portfolio
- 6.1.5 AbbVie Inc. Recent Developments
- 6.2 BlueWillow Biologics Inc.
- 6.2.1 BlueWillow Biologics Inc. Company Information
- 6.2.2 BlueWillow Biologics Inc. Business Overview
- 6.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product Portfolio
- 6.2.5 BlueWillow Biologics Inc. Recent Developments
- 6.3 Camurus AB
- 6.3.1 Camurus AB Company Information
- 6.3.2 Camurus AB Business Overview
- 6.3.3 Camurus AB Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Camurus AB Nanotechnology-based Drug Delivery Product Portfolio
- 6.3.5 Camurus AB Recent Developments
- 6.4 Celgene, lnc.
- 6.4.1 Celgene, lnc. Company Information
- 6.4.2 Celgene, lnc. Business Overview
- 6.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Product Portfolio
- 6.4.5 Celgene, lnc. Recent Developments
- 6.5 Cristal Therapeutics
- 6.5.1 Cristal Therapeutics Company Information
- 6.5.2 Cristal Therapeutics Business Overview
- 6.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Product Portfolio
- 6.5.5 Cristal Therapeutics Recent Developments
- 6.6 EyePoint Pharmaceuticals
- 6.6.1 EyePoint Pharmaceuticals Company Information
- 6.6.2 EyePoint Pharmaceuticals Business Overview
- 6.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product Portfolio
- 6.6.5 EyePoint Pharmaceuticals Recent Developments
- 6.7 Johnson and Johnson
- 6.7.1 Johnson and Johnson Company Information
- 6.7.2 Johnson and Johnson Business Overview
- 6.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Product Portfolio
- 6.7.5 Johnson and Johnson Recent Developments
7 North America
- 7.1 North America Nanotechnology-based Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 7.3 North America Nanotechnology-based Drug Delivery Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Nanotechnology-based Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 8.3 Europe Nanotechnology-based Drug Delivery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Nanotechnology-based Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Nanotechnology-based Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 10.3 South America Nanotechnology-based Drug Delivery Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Nanotechnology-based Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Nanotechnology-based Drug Delivery Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst